Weight Loss & Metabolic Health
What Is the GLP-1 and Addiction?
Last reviewed: May 2026 · Haute MD Editorial Team
GLP-1 medications are increasingly studied for their effects on addictive behaviors — alcohol use disorder, opioid use disorder, smoking, and behavioral addictions. Many patients report spontaneous reduction in alcohol consumption, gambling urges, and compulsive eating while on semaglutide or tirzepatide. Formal randomized trials are ongoing.
The clinical observations
Patients on GLP-1s frequently report decreased interest in alcohol, fewer cravings for tobacco, and reduced compulsive behaviors. Observational studies and emerging RCT data suggest meaningful reductions in alcohol use disorder severity.
How it might work
GLP-1 receptors are present in brain reward circuitry, including the ventral tegmental area and nucleus accumbens. GLP-1 signaling appears to reduce dopamine responses to addictive substances and behaviors, dampening reward and craving.
Current status
GLP-1s are not yet FDA-approved for addiction treatment. Off-label use is increasing, and RCTs are underway. Patients with addiction concerns should discuss with their physician.
Frequently Asked Questions
Will GLP-1s cure my alcohol use disorder?
No — but they may significantly reduce cravings as an adjunct to standard treatment.
Can I use GLP-1s for smoking cessation?
Off-label evidence is promising; not yet FDA-approved for this use.
Do GLP-1s help with food addiction?
Yes — by both physiological appetite reduction and dampening of reward circuit responses.
Is it safe to combine with addiction medications?
Generally yes — but coordinate with your prescriber to monitor effects.
Get Help Now
Speak with a Haute MD Internal Medicine physician
Dr. Alexander Golberg
Internal Medicine · New York, NY
View Profile
Dr. Kern Brar
MD
Internal Medicine · Oceanside, CA
View ProfileAre you a Internal Medicine physician?
Join Haute MD Network and have your profile featured alongside these answers.
Apply for the NetworkRelated Guides
Guide · WEIGHT LOSS & METABOLIC HEALTH
What Is Tirzepatide?
Tirzepatide is a dual GIP/GLP-1 receptor agonist (Mounjaro, Zepbound) that produces 20%+ weight loss in clinical trials. Learn how it works.
Read GuideGuide · WEIGHT LOSS & METABOLIC HEALTH
What Is Stress Eating?
Stress eating uses food to manage emotions rather than hunger. Learn what drives it and evidence-based strategies to break the cycle.
Read GuideGuide · WEIGHT LOSS & METABOLIC HEALTH
What Is Binge Eating Disorder?
Binge eating disorder (BED) is the most common eating disorder — characterized by recurrent episodes of uncontrolled overeating. Learn diagnosis and treatment.
Read Guide